Revisto
PrivateLast Round
Seed
Nov 18, 2024
Total Funding Raised
$8M
Company Overview
Revisto is a software company that provides an AI-powered platform to streamline and automate the medical, legal, and regulatory (MLR) review process for pharmaceutical and life sciences marketing materials.
Sector
Enterprise Software
Verticals
Compliance & Risk, RegTech, Vertical SaaS, Workflow Automation, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revisto Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Revisto Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2024 | ||||
| Pre Seed | Apr 23, 2024 |
Key People
Founding team and executive leadership
Revisto Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alloy Partners | Pre Seed |
| Tau Ventures | Seed |
| A-Squared Ventures | Seed |
| LiveOak Ventures | Seed |
Revisto Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Revisto's valuation, stock price, and market status.